CSE: HAVN
OTC: HAVLF
FRA: 5NP
Get Notified
Edit Content
Main Menu
CSE: HAVN
OTC: HAVLF
FRA: 5NP

US FDA

Psychedelic Science Holds Promise for Mainstream Medicine

Leave a Comment / Education, Health & Performance, Psychedelics / By

UNLV Neuroscientists’ Work on Brain Activity Recently Published by Nature: Scientific Reports Psychedelic healing may sound like a fad from the Woodstock era, but it’s a field of study that’s gaining traction in the medical community as an effective treatment option for a growing number of mental health conditions. While the study of psychedelics as medicine …

Psychedelic Science Holds Promise for Mainstream Medicine Read More »

Hundreds of Canadians Already Struggling With Mental Health Conditions Plead for Access to Psychedelic Medicine

Leave a Comment / Education, Health & Performance, Psychedelics / By

ATMA and SYNTAC Institute Collaborate to Submit a Group Application for Section 56 Exemption from Health Canada to Access Psychedelic Therapy ATMA Journey Centers Inc. (ATMA), an Alberta-based company focused on delivering innovative psychedelic-assisted therapies internationally, announced today that it has submitted a Group Application for Section 56 Exemption to Health Canada on behalf of Canadians …

Hundreds of Canadians Already Struggling With Mental Health Conditions Plead for Access to Psychedelic Medicine Read More »